整合功能基因组学鉴定系统性红斑狼疮IRF5风险位点的因果遗传变异
该研究通过表观基因组分析和表达数量性状位点分析,结合CRISPR介导的缺失、激活和干扰等技术,鉴定出IRF5风险位点中rs4728142为功能性变异,其风险等位基因A通过影响ZBTB3结合和染色质状态上调IRF5表达,并在SLE患者单核细胞中验证了CRISPRi干预效果。
要点
- SLE风险SNP rs4728142位于增强子区域,风险等位基因A与IRF5表达升高相关。
- rs4728142通过影响ZBTB3结合亲和力和染色质状态调控IRF5表达。
- 在SLE患者单核细胞中,CRISPRi干扰该增强子可减弱疾病相关细胞因子的产生。
核心结论
- rs4728142-A等位基因通过影响ZBTB3结合、染色质状态并调控IRF5表达来增加SLE风险,建立了遗传变异与狼疮发病机制之间的生物学联系。
研究设计与样本
- 研究应用表观基因组分析和表达数量性状位点分析优先筛选IRF5位点的 putative 功能变异。
- 采用CRISPR介导的缺失、激活和干扰研究rs4728142的遗传功能,并用等位基因特异性染色质免疫沉淀-定量PCR和等位基因特异性甲醛辅助分离调控元件-定量PCR解析等位基因差异调控IRF5表达的机制。
- 使用CRISPRi方法在SLE患者单核细胞中评估干预效果。
主要发现
- SLE风险SNP rs4728142位于增强子区域,提示疾病相关调控功能,风险等位基因rs4728142-A与IRF5表达升高密切相关。
- 含rs4728142的区域可作为增强子调控IRF5表达。
- rs4728142影响锌指和BTB结构域蛋白3(ZBTB3)的结合亲和力,ZBTB3是参与调控的转录因子。
- 在SLE患者单核细胞中,基于CRISPR干扰该增强子调控可减弱疾病相关细胞因子的产生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: IRF5 plays a crucial role in the development of lupus. Genome-wide association studies have identified several systemic lupus erythematosus (SLE) risk single-nucleotide polymorphisms (SNPs) enriched in the IRF5 locus. However, no comprehensive genome editing-based functional analysis exists to establish a direct link between these variants and altered IRF5 expression, particularly for enhancer variants. This study was undertaken to dissect the regulatory function and mechanisms of SLE IRF5 enhancer risk variants and to explore the utilization of clustered regularly interspaced short palindromic repeat interference (CRISPRi) to regulate the expression of disease risk gene to intervene in the disease. METHODS: Epigenomic profiles and expression quantitative trait locus analysis were applied to prioritize putative functional variants in the IRF5 locus. CRISPR-mediated deletion, activation, and interference were performed to investigate the genetic function of rs4728142. Allele-specific chromatin immunoprecipitation-quantitative polymerase chain reaction and allele-specific formaldehyde-assisted isolation of regulatory element-quantitative polymerase chain reaction were used to decipher the mechanism of alleles differentially regulating IRF5 expression. The CRISPRi approach was used to evaluate the intervention effect in monocytes from SLE patients. RESULTS: SLE risk SNP rs4728142 was located in an enhancer region, indicating a disease-related regulatory function, and risk allele rs4728142-A was closely associated with increased IRF5 expression. We demonstrated that an rs4728142-containing region could act as an enhancer to regulate the expression of IRF5. Moreover, rs4728142 affected the binding affinity of zinc finger and BTB domain-containing protein 3 (ZBTB3), a transcription factor involved in regulation. Furthermore, in monocytes from SLE patients, CRISPR-based interference with the regulation of this enhancer attenuated the production of disease-associated cytokines. CONCLUSION: These results demonstrate that the rs4728142-A allele increases the SLE risk by affecting ZBTB3 binding, chromatin status, and regulating IRF5 expression, establishing a biologic link between genetic variation and lupus pathogenesis.
引用
- Hou G, Zhou T, Xu N, et al. Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus. Arthritis Rheumatol. 2023. PMID: 36245280. doi:10.1002/art.42390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。